Cagrilintide and GLP-1 Cycling
Cagrilintide is emerging as a key tool for breaking GLP-1 plateaus. By targeting amylin and calcitonin receptors instead of GLP-1 pathways, it supports appetite control during cycling phases and helps sustain results when receptor adaptation slows progress.